• EN - English
  • FR - français
  • IT - italiano
Parliamentary question - E-000869/2022(ASW)Parliamentary question
E-000869/2022(ASW)

Answer given by Ms Kyriakides on behalf of the European Commission

The Commission examined within the framework of Directive (EU) 2015/1535[1] in 2020 a French draft decree ‘on the provision of information enabling the identification of endocrine disruptors in a product[2]’ and in 2021 a French draft order establishing the list of substances with endocrine disrupting properties and the categories of products presenting a particular risk of exposure[3].

In both cases, the Commission issued comments to the French authorities highlighting that these drafts may not be aligned with the regulation on classification, labelling and packaging of substances and mixtures[4] (breach of Article 51 on the free movement) and with the REACH Regulation[5] (breach of Annex XII read in conjunction with Article 128 on free movement).

The Commission also pointed out that cholecalciferol was not identified as substances of very high concern (SVHCs) in accordance with Articles 57 and 59 of the REACH Regulation. This means that cholecalciferol is not to be considered as an endocrine disruptor also in food.

In light of that, the Commission considers that the authorisation of cholecalciferol as a source of Vitamin D in food supplements and fortified foods in accordance with Commission Regulation (EC) No 1170/2009[6] is scientifically supported[7].

Last updated: 17 May 2022
Legal notice - Privacy policy